Hydrocortisone ointment eye

Država: Armenija

Jezik: engleski

Izvor: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Aktivni sastojci:

hydrocortisone (hydrocortisone acetate)

Dostupno od:

Pharmaceutical Company Jelfa S.A.

ATC koda:

S01BA02

INN (International ime):

hydrocortisone (hydrocortisone acetate)

Doziranje:

5mg/g

Farmaceutski oblik:

ointment eye

Jedinice u paketu:

3g aluminium tube

Tip recepta:

Prescription

Status autorizacije:

Registered

Datum autorizacije:

2016-02-26

Svojstava lijeka

TTPII.TITA.fl
XAPAI{:TEPI4CTWK}I.JIEKAPCTBEIIHOTO
(SUMMARY
OF PR:ODUCT
CHARA
1.
HA3BA]II4E JIEKAPC1IBEIIHOTO
IPEIIAPATA
fr.r4poxoprnson
Hydrocortisone
Me44yuap
oAHo e
Herrareuto
B
aHH
o
e
rra3B
:lHr.r
e
:
f
i.rgpo
roprus
ou
2.
KATIE
CT
BEHHbtrZ
I{
KCUII{IIE
CTBEIIIIbIfr
C
O
CTAB
1
r
Masu
co;Iep)Kr{r:
neilcmewouLee
6eweclfi6o
:_
rt'Ic4poKoprrrcoHa
arlerar
5,0 rrtr
B
cnouorart)JrbHrre
B
eruecrBil:
nonnufi
uepeqeFrb
BcrIoMo
f
areJIbHbD(
3.
JIEKAP(]TBEHHA'I
@(]PMA
[I
NO3]IIPOBITA
Ma:r
rnannar
OllllcalrHe
Eena-fi
r{Jrr,r
rtorrrl4
6etas, oIHopoAHaJr npocBoquBaroqaJr
xr(pntuI
Macca.
4, KJITIHVTIIE
CKIIE
O C O
BEHH
O
CTI,I
4.1.
Ilonasa,Hnfl
K
npr{Meneunro
Alleprnuecxue
ga6oneeaufi;r
rJra3
(Aeplratnrrr
rerc,
6leQapur:ei,
KeparoKoHbronrrnnnrrr);
Brf,cnarraremnrrer
3a6oneBaHr{r
rre
oTc)'TcTBr4r,r
HapyrrreHr{{
ueJrocTHocrr,r
9[I{TerrE{
poroB}rrlbr
(6leoap
KeparoKorrbonrcrnnnru);
repuuuecrufi
v.
xlarr.rr{.recrnfi
oxor
orrl{Terrrnaq:au
geQerroB
poroBrrrlbr.
4.2.
Cuocob
rrpxMerrerrufl
H
Aosbr
Mecrso.
B
ronrrourr:usanrnuft
Merrrc)K
BBoA.sr
1
cu
rna:nofi
uaga
2-3
pwas
Kypc
leueuvx
|
-
2
HeAenr{.
flo
perouen4arJu[
BpaLra
Kypc
neqeHut
o
-
rsofisue,
Br{pycHbre,
ryr5ep6yne3Hbrq,
.
-
lJlayKoli{a;
.
-
TpaxoMa;
.
.
IIEPUO/I
BAKIII,IHAII}IX;
EIIAPATI
rcs)
cu.
uyr,rm
6.1..
KOH6IOHKT}II|II{T6I
I,I
oTAena
DraSa
rrFrr.r
,
KOHSIOHKTIj:.I3I/ITLI
U
(uocre
uomrc,fi
6rrtr
npc,gnen.
r';
,:i
3.-."t{a
-t
-
HapyrueHIUI
IIeJTO()THOC:CU
O6OnOqeK
fna3a;
-
tso3pa()'r
go
18
ner,
4.2$.
Ocodrre
yKa3anlrrr
rr
Dllprr
npeAocropolr(Hocrr{
lrpu
u
B0
epeut
JIeqeHr.I{
He
peKoMelrAyerc-rr
HoueHrre
KoHTaKTHbf,x
Jrr{E:3.
IJIIBHBIX
KaIIeJIb
I-IHTepBaII
BpeMeIIH
MelKIy
ItX
HHCTr.rJrJIx4ne>ft
U
Me.Eee
15
rrcln.
fltrru
upaue.ileur{rlr
6oree
10
aneft
ur
HaJr:aqlns.
B
anzrMHe3e
orKDrITo-
3arpbrroylolrnofi
fJlityKoMbn
ueo 6xo21ul,t
KoHrp,gy15
Brryrpl{Hlalnof
o
AaBJreHrr.f,
.
Ec.nu
y
rreLr1ueHTa
rrocJre
[pr{MeueHr{.s
[pelapara
BpeMeHHo
cH
qeTKocTb
3peHLIt,
IO
3AHI{MATBCS,BI4,IIAM,I{
ee
BoccTzrHoBJreHr.rr
He
peKoMeHAygTCr
yrrpaBmTb
aerovo6z:Iel,{
u
Aer{TeJr6HOci:t,
rpedyroqr.